Kadence Bio

Sevenoaks, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of a small-molecule therapeutic designed to address significant unmet needs in sexual and mental well-being. Kadence Bio is based in Sevenoaks, United Kingdom and was founded in 2021. Its last reported valuation was $25.2 million in Oct 2021. It has raised $16.3 million.

Last reported valuation
$25.2M
Oct 2026
Priced at
—
Total raised
$16.3M
Last round
—

Who backs Kadence Bio?

20 investors
InvestorType
Endless Frontier Labs—
Dhuna VenturesVenture capital
UCEA Capital PartnersFamily office
Apeiron CapitalHedge fund
Alexander LuikAngel
Lindemann Capital ManagementHedge fund
5 Horizons Capital—
Antoine Yazbek—
BC Growth Equity—
Cosmo Mellen—
+ 10 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kadence Bio investors

20 investors are on record for Kadence Bio, including Endless Frontier Labs, Dhuna Ventures, UCEA Capital Partners and Apeiron Capital.

Free account
More of Kadence Bio with a free account
  • ·The complete investor list: 20 names
  • ·Watch Kadence Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 20 firms already write checks for companies like Kadence Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View